Autocrine stimulatory mechanism by transforming growth factor β in human hepatocellular carcinoma

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1394-1402

  Matsuzaki, Koichi ^a   Date, Masataka ^a   Furukawa, Fukiko ^a   Tahashi, Yoshiya ^a   Matsushita, Masanori ^a   Sakitani, Kazushige ^a   Yamashiki, Noriyo ^a   Seki, Toshihito ^a   Saito, Hidetsugu ^b   Nishizawa, Mikio ^a   Fujisawa, Junichi ^a   Inoue, Kyoichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIGAND BINDING; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; CARCINOMA, HEPATOCELLULAR; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0034163388     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Massagué, J. TGF-β signal transduction. Annu. Rev. Biocheni., 67: 753-791, 1998.
2. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
3. Macías-Silva, M., Ahdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., and Wrana, J. L. MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87: 1215-1224, 1996.
4. Zhang, Y., Feng, X-H., Wu, R-Y., and Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature (Lond.). 383: 168-172, 1996.
5. Lagna. G., Hata, A., Hemmati-Brivanlou, A., and Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature (Lond.), 383: 832-836, 1996.
6. Chen, X., Rubock, M. J., and Whitman, M. A transcriptional partner for MAD proteins in TGF-β signaling. Nature (Lond.), 383: 691-696, 1996.
7. Labhe, E., Silvestri, C., Hoodless, P. A., Wrana, J. L., and Attisano, L. Smad 2 and Smad 3 positively and negatively regulate TGF-β dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell. 2: 109-120, 1998.
8. Zhang, Y., Feng, X-H., and Derynck, R. Smad 3 and Smad 4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature (Lond.), 394: 909-913, 1998.
9. Feng, X-H., Zhang, Y., Wu, R-Y., and Derynck, R. The tumor suppressor Smad 4/DPC 4 and transcriptional adaptor CBP/p300 are coactivators for Smad 3 in TGF-β-induced transcriptional activation. Genes Dev., 12: 2153-2163, 1998.
10. Wotton, D., Lo, R. S., Lee, S., and Massagué, J. A Smad transcriptional corepressor. Cell, 97: 29-39, 1999.
11. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
12. Imamura, T., Takase, M., Nishihara, A., Oeda. E., Hanai, J., Kawabata, M., and Miyazono, K. Smad 6 inhibits signalling by the TGF-β superfamily. Nature (Lond.). 389: 622-626, 1997.
13. Nakao, A., Afrakhte, M., Morén, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabala, M., Heldin, N-E., Heldin, C-H., and ten Dijke, P. Identification of Smad 7, a TGF-β-inducible antagonist of TGF-β signalling. Nature (Lond.), 389: 631-635, 1997.
14. Bedossa, P., Peltier, E., Terris, B., Franco, D., and Poynard, T. Transforming growth factor-β1 (TGF-β 1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology, 21: 760-766, 1995.
15. Shirai, Y., Kawata, S., Tamura, S., Ito, N., Tsusima, H., Takaishi, K., Kiso, S., and Matsuzawa, Y. Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Cancer (Phila.), 73: 2275-2279, 1994.
16. Date, M., Matsuzaki. K., Matsusita, M., Sakitani, K., Shibano, K., Okajima, A., Yamamoto, C., Ogata, N., Okumura, T., Seki, T., Kubota, Y., Kan, M., McKeehan, W. L., and Inoue, K. Differential expression of transforming growth factor-β and its receptors in hepatocytes and nonparenchymal cells of rat liver after CC14 administration. J. Hepatol., 28: 572-581, 1998.
17. Matsuzaki, K., Yoshitake, Y., Matuo, Y., Sasaki, H., and Nishikawa, K. Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc. Natl. Acad. Sci. USA, 86: 9911-9915, 1989.
18. Matsuzaki, K., Yoshitake, Y., Miyagiwa, M., Minemura, M., Tanaka, M., Sasaki, H., and Nishikawa, K. Production of basic fibroblast growth factor-like factor by cultured human cholangiocellular carcinoma cells. Jpn. J. Cancer Res., 81: 345-354, 1990.
19. Matsuzaki, K., Xu, J., Wang, F., McKeehan, W. L. Krummen, L., and Kan, M. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor β, or bone morphogenic factor. J. Biol. Chem., 268: 12719-12723, 1993.
20. Sakitani, K., Nishizawa, M., Inoue, K., Masu, Y., Okumura, T., and Ito, S. Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein β and nuclear factor-κB in hepatocytes. Genes Cells. 3: 321-330, 1998.
21. Matsushita, M., Matsuzaki, K., Date, M., Watanabe, T., Shibano, K., Nakagawa, T., Yanagitani, S., Amoh, Y., Takemoto, H., Ogata, N., Yamamoto, C., Kubota, Y., Seki, T., Inokuchi, H., Nishizawa, M., Takada, H, Sawamura, T., Okamura, A., and Inoue, K. Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development, Br. J. Cancer, 80: 194-205, 1999.
22. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C-H., Miyazono, K., and ten Dijke, P. TGF-β receptor-mediated signalling through Smad 2, Smad 3, and Smad 4. EMBO J., 16: 5353-5362, 1997.
23. Watanabe, T., Morizane, T., Tsuchimoto, K., Inagaki, Y., Munakata, Y., Nakamura, T., Kumagai, N., and Tsuchiya, M. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma. Int. J. Cancer, 32: 141-146, 1983.
24. Saito, H., Morizane, T., Watanabe, T., Kagawa, T., Iwabuti, N., Kumagai N., Inagaki, Y., Tsuchimoto, K., and Tsuchiya, M. Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer (Phila.), 64: 1054-1060, 1989.
25. Wieser, R., Wrana, J. L., and Massagué, J. GS domain mutations that constitutively activate TßR-I, the downstream signaling component in the TGF-β receptor complex. EMBO J., 14: 2199-2208, 1995.
26. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X-F., and Massagué, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
27. Afrakhte, M., Moren, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C-H., Heldin, N-E., and ten Dijke, P. Induction of inhibitory Smad 6 and Smad 7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun., 249: 505-511, 1998.
28. INK4B through a Sp1 consensus site. J. Biol. Chem., 270: 26750-26753, 1995.
29. Kurokawa, M., Mitani, K., Trie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., and Hirai, H. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad 3. Nature (Lond.), 394: 92-96, 1998.
30. Moustakas, A., and Kardassis, D. Regulation of the human p21/WAF1/Cip1 promoter in hepalic cells by functional interactions between Sp and Smad family members. Proc. Natl. Acad. Sci. USA, 95: 6733-6738, 1998.
31. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M., and Willson, J. K. V. Inactivation of the Type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
32. Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, A candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271; 350-353, 1996.
33. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Mellzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.